Ratings
0
Nobody has rated this yet. Be the first!
Works
2
2013 ESC guidelines on the management of stable coronary artery disease
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less
